---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038351"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2024-09-26T23:59:59+00:00"
generated_at: "2026-05-31T01:30:57.567121+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Qualigen CEO and CFO resign over disagreements; Board appoints interim CEO/CFO and President

## Summary
- Michael Poirier (CEO/Chairman) and Christopher Lotz (CFO) resigned immediately on Sep 23, 2024, citing disagreements over company's future direction.
- Board appointed Campbell Becher as President on Sep 25, 2024, effective immediately.
- Board appointed Kevin Richardson II as Interim CEO and Interim CFO on Sep 26, 2024; consulting fee $4,500 per week.
- Richardson previously served as CEO of Sanuwave Health, taking it from startup to $20M in revenue.
- Audit, Compensation, and Nominating committees reconstituted: Korenberg (Audit chair), Price (Comp chair), Lim (Nominating chair).

## SEC filing metadata
- accession: 0001493152-24-038351
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2024-09-26T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038351
- JSON: https://secwatch.observer/filing/0001493152-24-038351.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038351.txt

## Key facts
- Executive change
  Christopher Lotz resigned as Chief Financial Officer at AIxCrypto Holdings, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Mr. Christopher Lotz, Chief Financial Officer of the Company, also tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm
- Executive change
  Campbell Becher was appointed as President at AIxCrypto Holdings, Inc..
  - Action: appointed
  - Role: President
  source text: the board of directors (the “Board”) appointed Campbell Becher as President of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm
- Executive change
  Kevin Richardson II was appointed as Interim Chief Executive Officer and Interim Chief Financial Officer at AIxCrypto Holdings, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer and Interim Chief Financial Officer
  source text: the Board of Directors appointed Kevin Richardson II as the Interim Chief Executive Officer and Interim Chief Financial Officer, as well as a member of the board of directors of the Company (the “Interim CEO and CFO”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm
- Executive change
  Michael Poirier resigned as Chief Executive Officer and Chairman at AIxCrypto Holdings, Inc..
  - Action: resigned
  - Role: Chief Executive Officer and Chairman
  source text: Mr. Michael Poirier, Chief Executive Officer and Chairman of the board of directors of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm
- Executive change
  Kevin Richardson II was appointed as Director at AIxCrypto Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: as well as a member of the board of directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000149315224038351/0001493152-24-038351-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.